Material Safety Data Sheet
Salicylic acid
ACC# 20315
Section 1 - Chemical Product and Company Identification |
MSDS Name: Salicylic acid
Catalog Numbers:
AC147700000, AC147700010, AC385730000, AC419220000, AC419220020,
AC419220025, 41922-5000, A275-12, A275-212, A275-250LB, A275-500, A277-500
Synonyms:
o-Hydroxybenzoic acid; 2-Hydroxybenzoic acid.
Company Identification:
Fisher Scientific
1 Reagent Lane
Fair Lawn, NJ 07410
For information, call: 201-796-7100
Emergency Number: 201-796-7100
For CHEMTREC assistance, call: 800-424-9300
For International CHEMTREC assistance, call: 703-527-3887
Section 2 - Composition, Information on Ingredients
|
CAS# |
Chemical Name |
Percent |
EINECS/ELINCS |
69-72-7 |
Salicylic acid |
>99 | 200-712-3 |
Section 3 - Hazards Identification
|
EMERGENCY OVERVIEW
Appearance: white crystalline powder.
Warning! Causes severe eye irritation. Causes skin
and respiratory tract irritation. May be harmful if swallowed. Light
sensitive. May cause central nervous system effects. May cause
reproductive and fetal effects.
Target Organs: Kidneys, central nervous system,
pancreas.
Potential Health Effects
Eye:
Causes severe eye irritation. May result in corneal injury.
Skin:
Contact with skin causes irritation and possible burns, especially
if the skin is wet or moist. If absorbed, may cause symptoms similar
to those for ingestion. May cause skin rash and eruptions.
Ingestion:
Causes gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause "salicylism"; characterized by headache,
dizziness, ringing in the ears, hearing difficulty, visual
disturbances, mental confusion, drowsiness, sweating thirst,
hyperventilation, nausea, vomiting and diarrhea. Severe salicylate
intoxication may cause central nervous system disturbances such as
convulsions and coma, skin eruptions, and alteration in the
acid-base balance.
Inhalation:
Causes irritation of the mucous membrane and upper respiratory
tract.
Chronic:
May cause reproductive and fetal effects. Laboratory experiments
have resulted in mutagenic effects. May cause salicylism with effects
similar to those of skin absorption. May cause damage to the kidneys
and pancrease.
Section 4 - First Aid Measures
|
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid imme
diately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse.
Ingestion:
Call a poison control center. If swallowed, do not induce vomiting
unless directed to do so by medical personnel. Never give anything by
mouth to an unconscious person. Get medical aid.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
Follow with gastric lavage with activated charcoal. If available,
administer ferric hexacyanoferrate as a gastrointestinal trapping
agent. Persons with pre-existing skin disorders, eye problems, or
impaired kidney function may be more susceptible to the effects of
this substance.
Section 5 - Fire Fighting Measures
|
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Dusts at sufficient concentrations can form
explosive mixtures with air. During a fire, irritating and highly
toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
For small fires, use dry chemical, carbon dioxide, water spray or
alcohol-resistant foam. Water or foam may cause frothing. Use agent
most appropriate to extinguish fire.
Flash Point: 157 deg C ( 314.60 deg F)
Autoignition Temperature: 535 deg C ( 995.00 deg F)
Explosion Limits, Lower:1.1 % @ 200癈
Upper: Not available.
NFPA Rating:
(estimated) Health: 0; Flammability: 1; Instability: 0
Section 6 - Accidental Release Measures
|
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid generating dusty conditions. Remove all sources of
ignition. Provide ventilation.
Section 7 - Handling and Storage
|
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Avoid ingestion and inhalation.
Storage:
Keep away from sources of ignition. Do not store in direct sunlight.
Store in a cool, dry, well-ventilated area away from incompatible
substances. Store protected from moisture.
Section 8 - Exposure Controls, Personal Protection
|
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
Chemical Name |
ACGIH |
NIOSH |
OSHA - Final PELs |
Salicylic acid
|
none listed
|
none listed
|
none listed
|
OSHA Vacated PELs:
Salicylic acid:
No OSHA Vacated PELs are listed for this chemical.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
Section 9 - Physical and Chemical Properties
|
Physical State: Crystalline powder
Appearance: white
Odor: odorless - slight phenolic odor
pH: 2.4
Vapor Pressure: 0.000082 mm Hg
Vapor Density: No data
Evaporation Rate:Negligible
Viscosity: Not available.
Boiling Point: 211 deg C @ 20 mmHg
Freezing/Melting Point:158 - 160 deg C
Decomposition Temperature:Not available.
Solubility: Soluble.
Specific Gravity/Density:1.4400g/cm3
Molecular Formula:C7H6O3
Molecular Weight:138.12
Section 10 - Stability and Reactivity
|
Chemical Stability:
Stable under normal temperatures and pressures. Moisture sensitive.
Light sensitive. Darkens on exposure to light.
Conditions to Avoid:
High temperatures, incompatible materials, light, moisture, strong
oxidants.
Incompatibilities with Other Materials:
Oxidizing agents, lead acetate, iron salts, alkalis, iodine, spirit
nitrous ether.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide.
Hazardous Polymerization: Will not occur.
Section 11 - Toxicological Information
|
RTECS#:
CAS# 69-72-7:
VO0525000
LD50/LC50:
CAS# 69-72-7:
Draize test, rabbit,
eye: 100 mg Severe;
Draize test,
rabbit, skin: 500 mg/24H Mild;
Inhalation, rat: LC50 = >900
mg/m3/1H;
Oral, mouse: LD50 = 480
mg/kg;
Oral, rabbit: LD50 = 1300
mg/kg;
Oral, rat: LD50 = 891
mg/kg;
Skin, rabbit: LD50 = >10
gm/kg;
Skin, rat: LD50 = >2
gm/kg;
.
Carcinogenicity:
CAS# 69-72-7:
Not listed by ACGIH, IARC, NTP, or CA Prop 65.
Epidemiology:
No information found
Teratogenicity:
Oral, rat: TDLo = 1050 mg/kg (female 8-14 day(s) after
conception) Specific Developmental Abnormalities - Central
Nervous System and craniofacial (including nose and tongue)
and musculoskeletal system.; Oral, rat: TDLo = 350 mg/kg
(female 8-14 day(s) after conception) Effects on Embryo or
Fetus - extra-embryonic structures (e.g., placenta,
umbilical cord).; Oral, mouse: TDLo = 1 gm/kg (female 17
day(s) after conception) Fertility - post-implantation
mortality (e.g. dead and/or resorbed implants per total
number of implants) and fetotoxicity (except death, e.g.,
stunted fetus).
Reproductive Effects:
Oral, rat: TDLo = 1050 mg/kg (female 8-14 day(s) after
conception) Maternal Effects - uterus, cervix, vagina and
Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants) and litter
size (e.g. # fetuses per litter; measured before birth).;
Oral, rat: TDLo = 40 mg/kg (female 20-21 day(s) after
conception) Maternal Effects - parturition.
Mutagenicity:
Mutation in Microorganisms: Saccharomyces cerevisiae = 1
mmol/L/3H.; DNA Inhibition: Oral, mouse = 100 mg/kg.
Neurotoxicity:
No information found
Other Studies:
Section 12 - Ecological Information
|
Ecotoxicity:
Bacteria: Phytobacterium phosphoreum: EC50 = 214 mg/L; 5 min;
Microtox test
Adsorption, volatilization and bioconcentration are not expected to
be important environmental fate processes. Biodegradation is expected
to be the dominant removal mechanism from soil and water. It may also
undergo photochemical degradation in sunlit environmental media.
Environmental:
In air, it is expected to exist in both the vapor and particulate
phase. Vapor phase reaction with photochemically produced hydroxyl
radicals may be important (estimated half-life of 1.2 days). Removal
by wet and dry deposition can also occur. BOD = 141%, 5 days.
Physical:
Rapidly degrades to phenol when heated.
Other:
Dangerous to aquatic life in high concentrations.
Section 13 - Disposal Considerations
|
Chemical waste generators must determine whether a discarded chemical is classified
as a hazardous waste.
US EPA guidelines for the classification determination are listed in 40 CFR Parts 261.3.
Additionally, waste generators must consult state and local hazardous waste regulations to
ensure complete and accurate classification.
RCRA P-Series: None listed.
RCRA U-Series: None listed.
Section 14 - Transport Information
|
|
US DOT |
Canada TDG |
Shipping Name: |
Not regulated |
Not Regulated |
Hazard Class: |
|
|
UN Number: |
|
|
Packing Group: |
|
|
Section 15 - Regulatory Information
|
US FEDERAL
TSCA
CAS# 69-72-7 is listed on the TSCA inventory.
Health & Safety Reporting List
None of the chemicals are on the Health & Safety Reporting List.
Chemical Test Rules
None of the chemicals in this product are under a Chemical Test Rule.
Section 12b
None of the chemicals are listed under TSCA Section 12b.
TSCA Significant New Use Rule
None of the chemicals in this material have a SNUR under TSCA.
CERCLA Hazardous Substances and corresponding RQs
None of the chemicals in this material have an RQ.
SARA Section 302 Extremely Hazardous Substances
None of the chemicals in this product have a TPQ.
SARA Codes
CAS # 69-72-7: immediate, delayed.
Section 313
No chemicals are reportable under Section 313.
Clean Air Act:
This material does not contain any hazardous air pollutants.
This material does not contain any Class 1 Ozone depletors.
This material does not contain any Class 2 Ozone depletors.
Clean Water Act:
None of the chemicals in this product
are listed as Hazardous Substances under the CWA.
None of the chemicals in this
product are listed as Priority Pollutants under the CWA.
None of the chemicals in this
product are listed as Toxic Pollutants under the CWA.
OSHA:
None of the chemicals in this product
are considered highly hazardous by OSHA.
STATE
CAS# 69-72-7 is not present on
state lists from CA, PA, MN, MA, FL, or NJ.
California Prop 65
California No Significant Risk Level:
None of the chemicals in this product are listed.
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols:
XN
Risk Phrases:
R 22 Harmful if swallowed.
R 37/38 Irritating to respiratory system and skin.
R 41 Risk of serious damage to eyes.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately with plenty of
water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face protection.
WGK (Water Danger/Protection)
CAS# 69-72-7: 1
Canada - DSL/NDSL
CAS# 69-72-7 is listed on Canada's DSL List.
Canada - WHMIS
This product has a WHMIS classification of D2B.
This product has been classified in accordance with the hazard
criteria of the Controlled Products Regulations and the MSDS
contains all of the information required by those regulations.
Canadian Ingredient Disclosure List
CAS# 69-72-7 is listed on the Canadian Ingredient Disclosure List.
Section 16 - Additional Information
|
MSDS Creation Date: 6/10/1999
Revision #6 Date: 2/15/2008
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall Fisher be liable
for any claims, losses, or damages of any third party or for lost profits
or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if Fisher has been advised of
the possibility of such damages.